Archives
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
br Introduction Percutaneous transcatheter device closure
2019-05-10

Introduction Percutaneous transcatheter device closure of atrial septal defects (ASD) has become an effective alternative therapy to surgical repair in patients with secundum type ASD. Amplatzer ASD or ventricular septal defect (VSD) occluders were used for the closure of ASDs or VSDs, respective
-
The further investigation was performed by using MEM M
2019-05-10

The further investigation was performed by using MEM-M6/6 antibody to observe the linkage exits between CD147 and P-gp activity by intracellular Rho123 accumulation. MEM-M6/6 treatment did not alter Rho123 accumulation in drug-resistant K562/ADR cells. In contrast, the fluorescence intensity of Rho1
-
br Conflict of interest br Introduction The use of implantab
2019-05-10

Conflict of interest Introduction The use of implantable defibrillation devices such as an implantable cardioverter–defibrillator (ICD) or a cardiac resynchronization therapy device with a defibrillator (CRT-D) is the primary therapy for improving prognoses of patients with life-threatening ve
-
br Discussion We herein report a case of inappropriate
2019-05-10

Discussion We herein report a case of inappropriate shock therapy that was caused by T-wave oversensing and that occurred when the patient had sinus tachycardia and was squatting. Several methods were considered to troubleshoot this problem. We decreased the sensitivity and increased the NID and
-
igf 1 antagonist Chronic myelomonocytic leukemia has been re
2019-05-09

Chronic myelomonocytic leukemia has been reported as the most prevalent concomitant hematological neoplasm, followed by myelodysplastic, myeloproliferative syndrome, and acute myeloid leukemia; on the other hand, Lymphoproliferative neoplasms were less frequency associated with SM-AHMND. In another
-
In our study we observed that MT produced
2019-05-09

In our study we observed that MT produced a 50% improvement in the % area of tissues covered over that of H&E. It is possible that its three-in-one (trichrome) combination of dyes may be responsible for the large % area covered and high intensity measurement. This is in line with the report of Stree
-
br Conclusion br Conflict of interest br Introduction Giant
2019-05-09

Conclusion Conflict of interest Introduction Giant cell tumor (GCT) is a primary intramedullary bone tumor that is composed of mononuclear and giant mononuclear cells, resembling inhibitor of catalase [1]. It usually involves the end of a long bone. The World Health Organization has classi
-
Si recordamos que la edici n de El
2019-05-09

Si recordamos que la edición de El fistol del diablo es de 1887, y que la de Los bandidos de Río Frío de 1891, podemos deducir que en sus últimos años de vida, Payno concibió y planteó su idea del proceso histórico nacional en el que la tradición mexicana y la modernización nacional logran al fin un
-
Inhaled corticosteroids long acting agonists
2019-05-09

Inhaled corticosteroids, long-acting β-agonists, and long-acting muscarinic agonists are all expensive drugs and many patients in China cannot afford them. An alternative pharmacological treatment for COPD, phosphodiesterase-4 inhibitor, is awaiting approval by the China State Food and Drug Administ
-
The median standardised inclusion score for
2019-05-09

The median standardised inclusion score for the 70 countries reviewed was 1·53 (IQR 0·63–2·09), corresponding to a reasonable level of inclusion. Countries showing best practice (score of 4) were Moldova, Ghana, Serbia, and the Dominican Republic. 20 countries (29%) showed strong inclusion, 25 count
-
Precisamente en ese a o de llegar a a
2019-05-09

Precisamente, en ese año de 1569, llegaría zip inhibitor Perú el virrey Francisco de Toledo, quien iniciaría, en 1572, un proceso judicial frente a don Carlos y don Felipe Yupanqui por su supuesto involucramiento en la revuelta del Inca sublevado en Vilcabamba, Túpac Amaru. Una de las consecuencias
-
br Conclusions br Limitation br Acknowledgments This researc
2019-05-09

Conclusions Limitation Acknowledgments This research was supported in part by the China Postdoctoral Science Foundation (Nos. 2013M542478 and 2015T81139), a Grant (no. 2014FB059) from the Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical Uni
-
br Conflict of interest br Disclosures br Acknowledgments br
2019-05-09

Conflict of interest Disclosures Acknowledgments Patient presentation A 64-year-old male with a history of a right ventricular outflow tract ventricular tachycardia (RVOT-VT) ablation presented from an outlying hospital due to four recent episodes of non-exertional syncope. He had three
-
Validation study findings showed that knowledge KR had moder
2019-05-09

Validation study findings showed that knowledge (KR20=0.58) had moderate internal consistency. Even though this was fairly acceptable, the knowledge domain was considered a good test as KR20 tends to result in more conservative estimates than Cronbach’s alpha [28]. Enhancing the reliability of a que
-
Conflict of interest br Introduction Nifekalant hydrochlorid
2019-05-08

Conflict of interest Introduction Nifekalant hydrochloride was first approved by the Japanese Ministry of Health, Labour and Welfare in 1999 and is now used as a first-line antiarrhythmic drug for refractory ventricular tachyarrhythmias in the country [1]. Nifekalant is a class III antiarrhythmi
16276 records 1075/1086 page Previous Next First page 上5页 10711072107310741075 下5页 Last page